Literature DB >> 10048594

Ionic effects on human recombinant P2X7 receptor function.

A D Michel1, I P Chessell, P P Humphrey.   

Abstract

The actions of monovalent and divalent ions on the P2X7 receptor have been assessed by measuring their effect on responses to the P2 receptor agonist, 2'- and 3'-O-(4-benzoyl-benzoyl)-ATP (DbATP), in HEK293 cells expressing the human recombinant P2X7 receptor. In these cells, DbATP increased the cellular accumulation of the DNA binding, fluorescent dye, YO-PRO-1. The potency of DbATP to elicit this effect was decreased by both calcium and magnesium ions. In addition, when the pH was increased above 8 or reduced below 6.5, the potency of DbATP was less than obtained at pH 7.5. Monovalent ions also affected the P2X7 receptor such that the potency of DbATP was 19-fold higher in NaCl-free buffer containing 280 mM sucrose (pEC50=6.48) than in 140 mM NaCl containing buffer (pEC50=5.19). Monovalent cations differentially affected the potency of DbATP. Thus, when the chloride concentration was maintained at 140 mM, pEC50 values for DbATP were 6.14, 5.87 and 5.19 when the counter cation was 140 mM choline, potassium or sodium, respectively. Monovalent anions also differentially affected the potency of DbATP and in the presence of 140 mM sodium ions, pEC50 values for DbATP were 6.14, 6.07, 5.19 and 4.53, respectively, when the counter anion was 140 mM aspartate, glutamate, chloride or iodide. The inhibitory effect of monovalent anions on P2X7 receptor function was also observed in electrophysiological studies. Thus in sodium glutamate containing buffer the potency of DbATP (pEC50=5.55) was approximately 22-fold higher than in NaCl containing buffer (pEC50=4.20). This study has demonstrated that P2X7 receptor function can be markedly affected by a wide range of ions and that physiological concentrations of sodium and chloride ions, as well as divalent cations, contribute to the low potency of ATP as an agonist at this receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048594     DOI: 10.1007/pl00005328

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.

Authors:  A D Michel; M Xing; P P Humphrey
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Apparent species differences in the kinetic properties of P2X(7) receptors.

Authors:  A D Hibell; E J Kidd; I P Chessell; P P Humphrey; A D Michel
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Proteomic and functional evidence for a P2X7 receptor signalling complex.

Authors:  M Kim; L H Jiang; H L Wilson; R A North; A Surprenant
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

4.  Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems.

Authors:  S A Deuchars; L Atkinson; R E Brooke; H Musa; C J Milligan; T F Batten; N J Buckley; S H Parson; J Deuchars
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

5.  P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.

Authors:  Safina Gadeock; Aleta Pupovac; Vanessa Sluyter; Mari Spildrejorde; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-06-05       Impact factor: 3.765

6.  P2X7 receptors in Müller glial cells from the human retina.

Authors:  T Pannicke; W Fischer; B Biedermann; H Schädlich; J Grosche; F Faude; P Wiedemann; C Allgaier; P Illes; G Burnstock; A Reichenbach
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 7.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

8.  Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue.

Authors:  E Fonfria; W C Clay; D S Levy; J A Goodwin; S Roman; G D Smith; J P Condreay; A D Michel
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects.

Authors:  A D Michel; W C Clay; S W Ng; S Roman; K Thompson; J P Condreay; M Hall; J Holbrook; D Livermore; S Senger
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

10.  Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland.

Authors:  Robin R Hodges; Joanna Vrouvlianis; Marie A Shatos; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.